Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS.
Ontology highlight
ABSTRACT: Prion protein (PrP) concentration controls the kinetics of prion replication and is a genetically and pharmacologically validated therapeutic target for prion disease. In order to evaluate PrP concentration as a pharmacodynamic biomarker and assess its contribution to known prion disease risk factors, we developed and validated a plate-based immunoassay reactive for PrP across 6 species of interest and applicable to brain and cerebrospinal fluid (CSF). PrP concentration varied dramatically across different brain regions in mice, cynomolgus macaques, and humans. PrP expression did not appear to contribute to the known risk factors of age, sex, or common PRNP genetic variants. CSF PrP was lowered in the presence of rare pathogenic PRNP variants, with heterozygous carriers of P102L displaying
SUBMITTER: Mortberg MA
PROVIDER: S-EPMC8986079 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA